Clinical trials: Allergic Rhinitis Due to Grass Pollen
Allergic Rhinitis Due to Grass Pollen
Prospective Observational Study for Determination of Minimal Clinically Important Difference of Allergic Rhinitis Symptoms Due to Grass Pollen (Equinoxe 2)
Prospective multi-center study carried out in France involving patients with allergic rhinitis. Study in usual care where no specific diagnostic or therapeutic procedure is required.
- Trial name
- NCT01953471
- Testing
- Allergic rhinitis
- Where
- France
- Volunteers
- 959 people
- Sponsor
- Hopital Foch
Allergic Rhinitis Due to Grass Pollen
ILIT: Follow-up of Rhinitis Quality of Life
Re-evaluation of patients treated with intralymphatic immunotherapy (ILIT) in terms of quality of life and therapeutic efficacy and comparison with subcutaneous immunotherapy (SCIT) 15 years post immunotherapy
- Trial name
- NCT05037955
- Where
- Switzerland
- Volunteers
- 162 people
- Sponsor
- University of Zurich
Allergy to Grass Pollen, Allergic Rhinitis Due to Weed Pollens
Grass Sensitisation and Allergic Rhinitis in Thai Patients
Allergic rhinitis patients are the patients who have nasal symptoms when triggered by indoor or outdoor allergens. Outdoor allergen can be divided into grass, tree, or weed.
- Trial name
- NCT01686022
- Testing
- Immunoblot
- Where
- Thailand
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Mahidol University
Allergic Rhinitis Due to Weed Pollen, Montelukast
Early Intervention in Allergic Patients
As many as 250 million people suffer from allergic rhinitis in China, which has a large population, early use of drugs may help better control the symptoms.This study aimed to investigate the effects of early interventional…
- Trial name
- NCT05040828
- Testing
- Start taking Montelukast Sodium Tablets 10mg quaque die orally two weeks before peak pollen count., Montelukast Sodium Tablets 10mg quaque die orally was administered after peak pollen count., No oral drug therapy throughout the pollen period
- Where
- China
- Volunteers
- 59 people
- Sponsor
- Beijing Tongren Hospital
Seasonal Allergic Rhinitis
A Study of Tolerability and Safety of a New Cumulative Dose of Grass MATA MPL
There is increasing evidence that the effectiveness of allergy immunotherapy to control symptoms of rhinoconjunctivitis is related to the cumulative dose of allergen or allergoid administered during a single regimen of…
- Trial name
- G104 (NCT03931993)
- Testing
- Grass MATA MPL
- Where
- 4 sites in United States
- Volunteers
- 30 people
- Sponsor
- Allergy Therapeutics